PCA indicated that the use of all analyzed markers did not allow for the correct identification of RA patients and healthy blood donors (Fig. 1a), whereas the removal of ANA and ANCA markers enabled the identification of RA patients and healthy blood donors (Fig. 1b). The gene discussed is BTG3; the disease is rheumatoid arthritis.